Skip to content

Clinical trials

Phase 1/2 Urinary Bladder Neoplasms trials in Sweden

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Urinary Bladder Neoplasms Phase: Phase 1/2 Country / region: Sweden Clear all

5 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20131
20151
20171
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed2
Terminated2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Rainier Therapeutics2
Merck Sharp & Dohme LLC1
Seagen Inc.1
Uppsala University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Urinary Bladder Neoplasms5
Carcinoma, Transitional Cell2
Urinary Bladder Diseases2
Urologic Diseases2
Endometrial Neoplasms1
Esophageal Neoplasms1
Ovarian Neoplasms1
Prostatic Neoplasms1
Squamous Cell Carcinoma of Head and Neck1
Uterine Cervical Neoplasms1

Trials

Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.